Published

Evidence versus expectancy: the development of psilocybin therapy.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: BJPsych bulletin
Date: 2024-04-01
Source: PubMed
DOI: 10.1192/bjb.2023.28
PubMed: 37246405

Authors

Rucker JJ

Watch author

Derived topics and classifications

psilocybin Depression Clinical Trial Treatment-Resistant Depression Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Evidence versus expectancy: the development of psilocybin therapy.2024-04-01

Related papers

Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic ReviewOpen Science Framework · 2026-01-01 Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.Brain sciences · 2025-02-06 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-02 Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARASAIMSARA Journal · 2026-06-15 Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.Brain and behavior · 2026-06-01 Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-22